NEW YORK, Feb. 13, 2017 --- Despite the availability of powerful tools today to prevent, treat, and cure tuberculosis (TB) and malaria, why do these diseases continue to claim millions of lives? A new report released by amfAR, The Foundation for AIDS Research, titled “How Cures Can Fail,” explores the factors that have stymied worldwide efforts to eradicate TB and malaria – which have been around for thousands for years – and outlines the lessons that can be applied to the global response to HIV/AIDS.

The Trans-Pacific Partnership (TPP) is currently being negotiated among 12 Pacific Rim countries: Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the United States, and Vietnam. If passed, it will become the largest U.S. free trade agreement (FTA) in history. It is anticipated that the agreement will expand existing intellectual property (IP) protections on pharmaceutical products, which will ultimately impede access to affordable generic medicines for diseases such as HIV/AIDS, cancer, tuberculosis, and hepatitis C.